Login to Your Account

Frank Yu banks on U.S. life sci prospects

By Marie Powers
Staff Writer

Wednesday, February 12, 2014

Frank Yu wasn’t the most heralded participant at last month’s J.P. Morgan Healthcare (JPM) Conference in San Francisco, the giant partnering confab that draws biotechs, medtechs, pharmas and investors from around the world. Instead, Yu, founder and CEO of the $500 million Hong Kong private equity fund Themes Investment Partners and of the investment firm Ally Bridge Group, preferred to stay under the radar while assessing the pulse of the life sciences industry.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription